Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Travis Coy, ACA
VICE PRESIDENT - HEAD OF TRANSACTIONS AND M&A, ELI LILLY AND COMPANY
Eli Lilly and Company
Indianapolis, Indiana, United States
David Craig, MBA
PRESIDENT AND CEO, SARCOMATRIX THERAPEUTICS CORP
Sarcomatrix Therapeutics Corp.
Reno, Nevada, United States
Alan Crane, MBA
ENTREPRENEUR PARTNER, POLARIS PARTNERS
Crafting a Compelling Pitch to Seasoned Investors & Partners When Your Platform Offers a New Technology Approach in an Existing Field
Boston, Massachusetts, United States
Jack Crawford, MS
CEO, DEMEETRA AGBIO, INC
Demeetra AgBio, Inc.
Lexington, Kentucky, United States
Jason Criscione, PhD
CHIEF SCIENTIFIC OFFICER, ENQUYST TECHNOLOGIES INC
Enquyst Technologies Inc
Enquyst Technologies Inc
Lowell, Massachusetts, United States
Martin Crook
VICE PRESIDENT OF CORPORATE DEVELOPMENT ASSESSMENTS, BRISTOL MYERS SQUIBB
Bristol Myers Squibb
Kyriea Crudup
ALUMNA, MOREHOUSE SCHOOL OF MEDICINE
Creating Higher Educational Pipelines in Biotechnology that Addresses Diversity, Equity, and Inclusion
Marisa Cruz, MD
CHIEF MEDICAL OFFICER, EMPATICA
Advancing Digital Health Innovation in the Gray Space of Evolving FDA Regulations: What to Expect in 2023 and Beyond
Jasmin Cui, PhD
CEO AND CO-FOUNDER, INNOCARE
Forging Biotech Alliances in China
Kevin Curran, PhD
SCIENTIFIC ADVISOR AND INSTRUCTOR, BIOTECH PRIMER
Introduction to Cell Therapy